Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer
Vignesh T. Packiam(Rutgers, The State University of New Jersey), Patrick J. Hensley(University of Kentucky), Joon Kyung Kim(University of Kentucky), Yair Lotan(Southwestern Medical Center), Anand Rajan(Johns Hopkins Medicine), Stephanie J. T. Chen(University of Iowa), Derek B. Allison(University of Kentucky), Ian M. McElree(Vanderbilt University Medical Center), Viswesh Krishna(Vale (Brazil)), Vivek Nimgaonkar, Damir Vrabac(University of Pittsburgh Medical Center), Drew Watson, Stephen B. Williams(Cedars-Sinai Medical Center), Jordan R. Richards(University of Iowa), Waleed M. Abuzeid(University of Washington), Haochen Zhang, Anirudh Joshi, Michael A. O’Donnell(University of Iowa Health Care), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Saum Ghodoussipour(Rutgers, The State University of New Jersey)
Cited by 6
Related Papers
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
|Cell Metabolism|2018|297
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
|European Urology|2012|257
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy
|European Journal of Cancer|2013|170